Bio Pharma Dive
MARCH 26, 2021
In a Thursday meeting, advisers to the Food and Drug Administration concluded the companies didn't have a strong enough plan to mitigate the risks associated with tanezumab.
World of DTC Marketing
MARCH 26, 2021
QUICK READ: If you start to lose key people, you won’t be able to keep the business you do have, and things will go from bad to worse. Companies who see their good employees as “replaceable” are wrong. Good employees are not replaceable. Pharma cannot afford to let good people leave without so much as an exit interview to try and retain them. A colleague recently decided to leave her organization to join another pharma company.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Mirror
MARCH 26, 2021
One of the best gifts you can give to another person is a beautiful smile. Though it costs you nothing, it goes a long way in adding to others and you. It typically has a favourable effect on others, attracts people to you, and makes you approachable and likeable. A smile is very important. It is a part of your dressing and personality. Without a smile, you are incomplete, no matter how expensively and gorgeously dressed you are.
Scienmag
MARCH 26, 2021
Odontoblasts, the cells that form a tooth’s dentin, have a newly discovered function: Sensing cold, which can trigger pain in teeth; but scientists have also found a way to block the pathway to cold-sensitive teeth Credit: Copyright Katharina Zimmermann, MD, PhD BOSTON — Researchers report in Science Advances that they have uncovered a new function […].
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
pharmaphorum
MARCH 26, 2021
The UK Government and EU Commission trumpeted their Brexit trade deal, struck at the end of December, as ‘comprehensive’, the ‘biggest yet’ But a closer inspection of the EU-UK Trade and Cooperation Agreement (TCA) renders these statements largely illusory for the pharma sector. While pharma companies grapple with the effects of Brexit, there are undoubtedly a number of ways that the TCA benefits the sector, while leaving significant issues unanswered.
Scienmag
MARCH 26, 2021
Credit: WEI Wei Tumor targeting and intratumoral penetration are long-standing issues for cancer therapeutics. Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences and the University of Chinese Academy of Sciences (UCAS) have developed a new platelet-based formulation which demonstrated potent therapeutic effects against cancer in murine models.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Scienmag
MARCH 26, 2021
Credit: ©Science China Press In recent years, with the rapid development of flexible electronic skins, high-performance flexible tactile sensors have received more attention and have been used in many fields such as artificial intelligence, health monitoring, human-computer interaction, and wearable devices. Among various sensors, flexible capacitive tactile sensors have the advantages of high sensitivity, low […].
pharmaphorum
MARCH 26, 2021
Regeneron has posted findings from a large trial of its COVID-19 antibody cocktail showing the therapy reduced risk of hospitalisation or death by 70%. The US pharma said that the results were a landmark as they “conclusively” demonstrated that REGEN-COV (casirivimab+imdevimab) can significantly reduce death in an outpatient setting. Data from the phase 3 trial will also be used to convert an Emergence Use Authorisation into a permanent licence, Regeneron said.
Scienmag
MARCH 26, 2021
Credit: University of Huddersfield The University’s Professor Jason Roach will work alongside the National Police Wellbeing Service on a research project that will study to what extent the health and wellbeing of the nation’s police officers has been affected by the pandemic POLICE officers have had to overcome new obstacles and deal with challenges of […].
pharmaphorum
MARCH 26, 2021
There’s a new kid on the block among companies using artificial intelligence in drug discovery, after 1910 Genetics launched today with $26 million in financing. The Cambridge, Massachusetts-based startup claims it is the only biotech launched so far that will use AI to design both small-molecule drugs and protein therapeutics, coupled with automated biological testing to speed up drug development and reduce costs.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Scienmag
MARCH 26, 2021
Project spearheaded by Faculty of Medicine researcher to create a Canadian network for better researching and responding to the global threat COVID-19 variants pose Credit: The University of Ottawa A project spearheaded by a researcher at the University of Ottawa’s Faculty of Medicine has been awarded $9 million in Canadian Institutes of Health Research (CIHR) […].
Pharma Times
MARCH 26, 2021
New initiative aims to help researchers translate their ideas into innovations for cancer patients
Scienmag
MARCH 26, 2021
Scientists at St. Jude are studying how signals sent from skeletal muscle affect the brain Credit: St. Jude Children’s Research Hospital How do different parts of the body communicate? Scientists at St. Jude are studying how signals sent from skeletal muscle affect the brain. The team studied fruit flies and cutting-edge brain cell models called […].
Pharma Times
MARCH 26, 2021
Marketing authorisation application is seeking approval for advanced urothelial cancer
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
MARCH 26, 2021
NICT’s optical ground station successfully received downlink light from DLR’s small satellite-mounted optical terminal (OSIRISv1) Credit: NICT [Points] -Successful experiment to receive downlink light at NICT optical ground station from DLR optical terminal mounted on Univ. of Stuttgart’s Flying Laptop satellite -Succeeded in the initial experiment of the newly developed atmospheric turbulence measuring device and […].
XTalks
MARCH 26, 2021
With a number of COVID-19 vaccines now being authorized for use, how do we decide which is the best? Using data from COVID-19 vaccine trials from Pfizer/BioNTech, Oxford/AstraZeneca, Moderna and J&J, Ayesha explains why vaccine efficacies can’t be directly compared — and why vaccine messaging needs to reflect this. Listen to Episode 2 of the Xtalks Life Science Podcast to hear about Mira’s experience with getting vaccinated in the UAE, and why “COVID-19 vaccine shoppingR
Scienmag
MARCH 26, 2021
Credit: Armen Kemanian Renewable energy demand and consumption is at an all-time high in the United States. Shrub willow – a quick-growing woody crop – can be an excellent source of renewable bioenergy. The crop is harvested and turned into wood chips, which can be used for heat, mulch, animal bedding, biochar, and biofuel. In […].
XTalks
MARCH 26, 2021
In Episode 1 of the Xtalks Life Science Podcast, Sarah discusses a new condition called “Mask-Associated Dry Eye” and Ayesha talks about Droplet Micron, an innovative insulin needle. Tune into this episode to hear a clip from Sarah’s interview with Dr. Richard Hom, optometric director at Anthem Blue Cross and Blue Shield, who talks about the impact of prolonged screen time on eye health.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
MARCH 26, 2021
Credit: ORNL, U.S. Dept. of Energy A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs. The U.S. Food and Drug Administration recently acknowledged receipt of Oak Ridge National Laboratory’s drug master file for actinium-225 nitrate, which enables pharmaceutical companies to reference the document […].
XTalks
MARCH 26, 2021
In Episode 3 of the Xtalks Life Science Podcast, the team reflects on the 1-year anniversary of the start of the COVID-19 pandemic. Ayesha explains how far we’ve come since March 2020 in terms of vaccine development, but discusses the inequities in distribution of the COVID-19 vaccines despite the establishment of the WHO’s COVAX Facility. Ayesha also discusses the four largest cancer biotech acquisitions of 2021 so far, including deals made by Agilent, Takeda and Amgen.
Scienmag
MARCH 26, 2021
A new study reveals that the genetic uniqueness of the Basque population is not due to its external origin in respect of other Iberian populations, but reduced contacts as of the Iron Age. Credit: André Flores-Bello The Basques are a unique population in Western Europe; their language is not related to any Indo-European language. Furthermore, […].
XTalks
MARCH 26, 2021
In Episode 1 of the Xtalks Food Podcast, Sydney discusses Nestlé’s acquisition of functional beverage brand Essentia Water, a decision announced after the food giant dumped its bottled water portfolio. Essentia’s premium positioning may have motivated the purchase; however, the acquisition of a plastic bottled water brand calls into question Nestlé’s global sustainability goals.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
MARCH 26, 2021
Greatest increases are in Black men under 65 years old ‘A persistent and troubling rural disadvantage’ Strategies needed to support rural Americans CHICAGO —Heart failure deaths are persistently higher in rural areas of the United States compared with urban areas, reports a new Northwestern Medicine study. The research also showed race disparities in heart failure […].
Pharma Times
MARCH 26, 2021
British Heart Foundation-funded researchers hope findings can aid the development of new treatments
Scienmag
MARCH 26, 2021
Patients with lupus are more likely to have metabolic syndrome and insulin resistance – both factors linked to heart disease – if they have lower vitamin D levels, a new study reveals. Researchers believe that boosting vitamin D levels may improve control of these cardiovascular risk factors, as well as improving long-term outcomes for patients […].
XTalks
MARCH 26, 2021
What exactly is a sports drink made “from the goodness of milk”? In Episode 3 of the Xtalks Food Podcast, Mira tells the team about a sports drink made with an upcycled byproduct of the dairy industry. Also in this episode, Sydney talks about what it means to be carbon neutral in the food industry, and how even food giants like Maple Leaf can achieve this sustainability goal.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
MARCH 26, 2021
International genomics research led by the University of Leicester has used artificial intelligence (AI) to study an aggressive form of cancer, which could improve patient outcomes. International genomics research led by the University of Leicester has used artificial intelligence (AI) to study an aggressive form of cancer, which could improve patient outcomes.
pharmaphorum
MARCH 26, 2021
Comms company Envision Pharma Group has acquired doDOC Corp, a document collaborative review, editing and authoring firm. doDOC enables simultaneous collaboration in the review, editing, and authoring of documents among multiple users. Designed for the pharma and life sciences industries, it offers significant industry-specific advantages over general document authoring solutions in the market today.
Scienmag
MARCH 26, 2021
Every year, millions of people around the world are displaced from their homes due to severe weather caused by climate change. According to the International Red Cross and Red Crescent Movement, 10.3 million people were displaced as a result of climate-?related events in the last six months alone – four times the number displaced by […].
pharmaphorum
MARCH 26, 2021
After more than a decade of fraught clinical development it looks like the end of the line for Pfizer/Lilly painkiller tanezumab, which promised to be an alternative to addictive opioid painkillers. Pfizer has asked the FDA for a licence for tanezumab in moderate to severe osteoarthritis pain, where other painkillers aren’t working or are inappropriate.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
294 
Let's personalize your content